quinacrine has been researched along with Cancer of Ovary in 12 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Excerpt | Relevance | Reference |
---|---|---|
"Ten cases of cervical cancer were observed, compared with 12." | 1.36 | Cancer risk after sterilization with transcervical quinacrine: updated findings from a Chilean cohort. ( Guzmán, SC; Guzman-Serani, R; Hubacher, D; Sokal, DC; Trujillo, V; Wheeless, A, 2010) |
"Cohort study." | 1.31 | Cancer risk among women sterilized with transcervical quinacrine in Chile: an update through 1996. ( Dabancens, A; Guzman-Serani, R; Sokal, DC; Zipper, J, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (58.33) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 1 (8.33) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khurana, A | 1 |
Roy, D | 1 |
Kalogera, E | 1 |
Mondal, S | 1 |
Wen, X | 1 |
He, X | 1 |
Dowdy, S | 1 |
Shridhar, V | 1 |
Sokal, DC | 3 |
Trujillo, V | 1 |
Guzmán, SC | 1 |
Guzman-Serani, R | 2 |
Wheeless, A | 1 |
Hubacher, D | 1 |
Vach, TH | 1 |
Nanda, K | 1 |
McCann, MF | 1 |
Weiner, DH | 1 |
Drobnes, C | 1 |
Rochanawutanon, M | 1 |
Duc, NB | 1 |
Loan, ND | 1 |
ROCHLIN, DB | 1 |
SMART, CR | 1 |
WAGNER, DE | 1 |
SILVA, AR | 1 |
Kivi, S | 1 |
Mikelsaar, AV | 1 |
Dabancens, A | 1 |
Zipper, J | 1 |
Johnson, LP | 1 |
Rivkin, SE | 1 |
Weber, EL | 1 |
McCaw, B | 1 |
Hecht, F | 1 |
Linder, D | 1 |
Lovrien, EW | 1 |
Wyandt, H | 1 |
Bacon, D | 1 |
Clark, B | 1 |
Lea, N | 1 |
Mutch, DG | 1 |
Powell, CB | 1 |
Kao, MS | 1 |
Collins, JL | 1 |
Atkin, NB | 1 |
Lee, M | 1 |
Boyes, DA | 1 |
Farber, LR | 1 |
12 other studies available for quinacrine and Cancer of Ovary
Article | Year |
---|---|
Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinogenesis; Cell Death; Cell Line, Tumor; | 2015 |
Cancer risk after sterilization with transcervical quinacrine: updated findings from a Chilean cohort.
Topics: Chile; Cohort Studies; Databases, Factual; Endometrial Neoplasms; Female; Follow-Up Studies; Humans; | 2010 |
Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam.
Topics: Age Factors; Case-Control Studies; Confidence Intervals; Female; Genital Neoplasms, Female; Humans; | 2010 |
THE CONTROL OF RECURRENT MALIGNANT EFFUSIONS USING QUINACRINE HYDROCHLORIDE.
Topics: Ascites; Biomedical Research; Breast Neoplasms; Central Nervous System Diseases; Colonic Neoplasms; | 1964 |
Q- and C-band polymorphisms in patients with ovarian or breast carcinoma.
Topics: Adult; Aged; Azure Stains; Breast Neoplasms; Carcinoma; Chromosome Banding; Chromosomes, Human; Fema | 1980 |
Cancer risk among women sterilized with transcervical quinacrine in Chile: an update through 1996.
Topics: Adult; Breast Neoplasms; Cervix Uteri; Cohort Studies; Female; Follow-Up Studies; Humans; Neoplasms; | 2000 |
Palliation in malignant pleural effusion.
Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Drainage; Female; Hodgkin Disease; Humans; Lung Neopl | 1975 |
Ovarian teratomas: cytologic data.
Topics: Chromosomes; Female; Humans; Ovarian Neoplasms; Polymorphism, Genetic; Quinacrine; Staining and Labe | 1976 |
Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
Topics: Animals; Arachidonic Acid; Cell Line; Cell Survival; Drug Resistance; Emetine; Female; Humans; Mice; | 1992 |
Y bodies and similar fluorescent chromocentres in human tumours including teratomata.
Topics: Adenocarcinoma; Carcinoma; Colonic Neoplasms; Dysgerminoma; Female; Humans; Male; Microscopy, Fluore | 1973 |
The use of quinacrine hydrochloride for the control of malignant serous effusions.
Topics: Ascites; Female; Humans; Injections, Intraperitoneal; Ovarian Neoplasms; Quinacrine; Remission, Spon | 1971 |
Correctable complications of neoplastic disease. 3. Neoplastic effusions.
Topics: Alkylating Agents; Ascitic Fluid; Breast Neoplasms; Drainage; Exudates and Transudates; Female; Huma | 1971 |